FDA’s Opioids Action Plan: A Midyear Checkup

FDA’s Opioids Action Plan: A Midyear Checkup

Public Notification: Zi Su Body Fat Health II (紫苏瘦身营养素 II – Zi Su Shou Shen Ying Yang Su II) Contains Hidden Drug Ingredient

10/25/2016 12:48 PM EDT

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Zi Su Body Fat Health II, a product promoted for weight loss. This product was identified by FDA during an examination of international mail shipments.

Alabama compounder slapped with FDA warning letter

October 25, 2016 | By Joseph Keenan

Eagle Pharmacy, an Alabama drug compounder, was slapped with a warning letter by the FDA for unsanitary conditions and failing to register new compounds.

Must Read! FDA's New Compounded Drug Guidances — What The Pharma ...

FDA's New Compounded Drug Guidances — What The Pharma ...

www.pharmaceuticalonline.com/.../fda-s-new-compounded-drug-guidances-what-the-...

3 hours ago - As a member of the pharmaceutical industry, you might be thinking, “Why should I read an article about how the FDA is tackling problems at drug compounding ..

September 20, 2016

Buderer Drug Company Inc

Cincinnati District Office

Compounding Pharmacy/Adulteration/Misbranding

Not Issued *

Not Issued *
August 10, 2016	Perfect Source Natural Products Inc.	Los Angeles District Office	CGMP/Dietary Supplement/Adulterated	Not Issued *

July 25, 2016

Right Value Drug Stores, Inc.

Dallas District Office

CGMP/Finished Pharmaceuticals/Adulterated/Misbranded

Not Issued *

July 29, 2016

NuVet Labs

Los Angeles District Office

New Animal Drug/Adulterated

Not Issued *

October 12, 2016

Threshold Enterprises Ltd

San Francisco District Office

CGMP/Dietary Supplement/Adulterated/Misbranded

Not Issued *

October 13, 2016

Teva Pharmaceutical Works Private Limited Company

Center for Drug Evaluation and Research

CGMP/Finished Pharmaceuticals/Adulterated

Not Issued *